Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is JiangXi Tianxin Pharmaceutical Co EV-to-FCF?
JiangXi Tianxin Pharmaceutical CoSHSE:603235 -0.25%79 EV-to-FCF is 153.26 as of Jul. 30, 2026, which is 416% above its 10-year median of 29.71. GuruFocus rates SHSE:603235 with a GF Score™ of 79/100 and a GF Value™ of ¥28.99 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 1,193 Consumer Packaged Goods companies, JiangXi Tianxin Pharmaceutical Co ranks worse than 94.64% on this metric.
SHSE:603235'
s EV-to-FCF Range Over the Past 10 Years
Min: -83.59 Med: 29.71 Max: 237.44
Current: 151.68
During the past 8 years, the highest EV-to-FCF of JiangXi Tianxin Pharmaceutical Co was 237.44. The lowest was -83.59. And the median was 29.71.
SHSE:603235's EV-to-FCF is ranked worse than 94.64% of 1193
companies
in the Consumer Packaged Goods industry
Industry Median: 16.01
vs SHSE:603235: 151.68
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
JiangXi Tianxin Pharmaceutical Co (SHSE:603235) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
JiangXi Tianxin Pharmaceutical Co's PE Ratio (TTM) for today is calculated as:
JiangXi Tianxin Pharmaceutical Co's share price for today is ¥23.96.
JiangXi Tianxin Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.190.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
JiangXi Tianxin Pharmaceutical Co EV-to-FCF Related Terms
JiangXi Tianxin Pharmaceutical Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, JiangXi Tianxin Pharmaceutical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JiangXi Tianxin Pharmaceutical Co EV-to-FCF vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, JiangXi Tianxin Pharmaceutical Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where JiangXi Tianxin Pharmaceutical Co's EV-to-FCF falls into.
JiangXi Tianxin Pharmaceutical Co's current Enterprise Value is ¥9,367 Mil.
JiangXi Tianxin Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥61 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JiangXi Tianxin Pharmaceutical Co (SHSE:603235) has a EV-to-FCF of 153.26 as of Jul. 30, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on JiangXi Tianxin Pharmaceutical Co and its competitors. This is 416% above median its historical median of 29.71. According to the industry distribution chart, JiangXi Tianxin Pharmaceutical Co ranks #1129 out of 1193 companies in the Consumer Packaged Goods industry, placing it in the top 94.6%.
Is JiangXi Tianxin Pharmaceutical Co's EV-to-FCF too high?
JiangXi Tianxin Pharmaceutical Co's current EV-to-FCF of 153.26 is 416% above median its 10-year median of 29.71. The Consumer Packaged Goods industry median EV-to-FCF is 16.01. JiangXi Tianxin Pharmaceutical Co's value of 153.26 is 857.3% above this industry median. Based on the distribution chart, JiangXi Tianxin Pharmaceutical Co ranks #1129 out of 1193 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, JiangXi Tianxin Pharmaceutical Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JiangXi Tianxin Pharmaceutical Co's EV-to-FCF compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, JiangXi Tianxin Pharmaceutical Co ranks #1129 out of 1193 companies for EV-to-FCF. This places JiangXi Tianxin Pharmaceutical Co in the lower half of its industry. The industry median EV-to-FCF is 16.01. JiangXi Tianxin Pharmaceutical Co's value of 153.26 is 857.3% above this benchmark. While the company's 10-year median is 29.71 vs. the industry median of 16.01, JiangXi Tianxin Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Consumer Packaged Goods company?
The median EV-to-FCF among Consumer Packaged Goods companies is 16.01, based on 1,193 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JiangXi Tianxin Pharmaceutical Co's current EV-to-FCF of 153.26 is 857.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on JiangXi Tianxin Pharmaceutical Co and its competitors. For the Consumer Packaged Goods industry, the median EV-to-FCF is 16.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JiangXi Tianxin Pharmaceutical Co's current EV-to-FCF is 153.26, which is 416% above median its own 10-year median of 29.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JiangXi Tianxin Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, JiangXi Tianxin Pharmaceutical Co (SHSE:603235) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥28.99, compared to a current price of ¥23.96 — trading 17.4% below its estimated fair value. The current EV-to-FCF is 153.26, which is 416% above median its 10-year median of 29.71 and 857.3% above the Consumer Packaged Goods industry median of 16.01. JiangXi Tianxin Pharmaceutical Co's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For JiangXi Tianxin Pharmaceutical Co (SHSE:603235), the current EV-to-FCF is 153.26 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Overvalued in 2026?
Based on GuruFocus' analysis, JiangXi Tianxin Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥23.96 is trading 17.4% below its estimated GF Value™ of ¥28.99.
GuruFocus considers JiangXi Tianxin Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for SHSE:603235:
EV-to-FCF: 153.26 (416% above median its 10-year median of 29.71)
GF Value™: ¥28.99 vs. price of ¥23.96 (17.4% below fair value)
Industry Position: 857.3% above the Consumer Packaged Goods median (#1129 of 1193)
No single metric tells the full story. See the SHSE:603235 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JiangXi Tianxin Pharmaceutical Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603235 has been successfully added to your 
